PROVETOP

Biotinylated Human IL-21 Protein

Catalog No: IL21-HB001

Species
Human
Expression System
E.coli
Tag
His, Avi
Activity
Activity verified

Product overview

Recombinant Biotinylated Human IL-21 Protein is expressed in E. coli with a His tag and Avi tag at the N-terminus. It contains amino acid residues Gln32-Ser162 (UniProt accession: Q9HBE4-1).

Product Details

Molecular Aliases
Interleukin-21; IL-21; Za11; CVID11;IL21;IL 21; Interleukin 21
Protein Length
Gln32-Ser162
Expression System
E.coli
Theoretical Molecular Weight
The protein has a predicted MW of 18.30 kDa same as Bis-Tris PAGE result.
Purity
> 95% as determined by Bis-Tris PAGE
Endotoxin
Less than 1 EU per μg by the LAL method.
Buffer / Formulation
Lyophilized from 0.22 μm filtered solution in 20mM NaAc, 500mM NaCl (pH 5.5). Normally 8% trehalose is added as protectant before lyophilization.
State
Lyophilized
Storage Conditions
-20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Reconstitution Advice
Dissolve the lyophilized protein in 20mM NaAc (pH 5.5). Please refer to the Certificate of Analysis for detailed instructions.

Data Display

Bis-Tris PAGE
IL21-HB001 Bis-Tris-PAGE-white result

Biotinylated Human IL-21 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

ELISA
IL21-HB001 ELISA result

Immobilized Human IL-21R, hFc Tag at 1μg/ml (100μl/Well) on the plate. Dose response curve for Biotinylated Human IL-21, His Tag with the EC50 of 4.7ng/ml determined by ELISA (QC Test).

Background

Interleukin-21 (IL-21), produced predominantly by CD4 T cells and natural killer T (NKT) cells, is a newly discovered member of the common γ-chain family of cytokines. It has been implicated in many immunological processes and has been linked to autoimmune diseases, allergies and other inflammatory diseases.

References

  1. Sim GC, Radvanyi L. The IL-2 cytokine family in cancer immunotherapy. Cytokine Growth Factor Rev. 2014 Aug;25(4):377-90. doi: 10.1016/j.cytogfr.2014.07.018. Epub 2014 Aug 1. PMID: 25200249.

Have questions about this product?

Our technical team can help with product selection, application questions and order support.

Contact Technical Support